Asenathi Ntlabakanye handed 18-month ban, ruling him out of 2027 Rugby World Cup final
The timing of the sanction could not be more devastating for the career of one of South Africa’s most prominent tighthead props. Asenathi Ntlabakanye, a vital component of both the Lions and the Springboks, has been handed an 18-month suspension following an anti-doping rule violation, a decision that effectively removes him from contention for the 2027 Rugby World Cup.
The suspension, imposed by an independent panel, is set to begin on May 13, 2026, and will conclude on November 13, 2026. In a cruel twist of scheduling, that final date coincides exactly with the day of the Rugby World Cup final, ensuring the prop will be unable to participate in the tournament’s most critical stage.
The Asenathi Ntlabakanye doping ban follows an investigation into an out-of-competition test conducted on May 22, 2025. The investigation revealed the presence of Anastrozole, a hormone and metabolic modulator, and was complicated by the player’s own self-declaration regarding the use of the prohibited anabolic steroid DHEA.
The substance findings and regulatory rulings
The complexities of the case lie in the distinction between the two substances identified during the testing process. According to a statement from the South African Institute for Drug-Free Sport (SAIDS), Anastrozole is classified as a “specified substance” under South African Anti-Doping Rules. Because of this classification, the presence of the hormone modulator does not trigger a mandatory suspension on its own.
However, the situation changed when Ntlabakanye self-declared the use of Dehydroepiandrosterone (DHEA), an anabolic steroid. The formal charges, issued on September 9, 2025, addressed both the presence of Anastrozole and the use of DHEA. The combination of these findings led the independent panel to the 18-month sanction.
SA Rugby has maintained that the use of DHEA was not an attempt to gain an illicit advantage, but rather a medical necessity. The organization claimed the substance was prescribed by a specialist physician early in 2025 for medical reasons and was administered with the explicit approval of a medical doctor.
Despite this medical defense, the Doping Tribunal has moved forward with the disqualification of the player’s individual achievements. The ruling states that all competitive results and personal benefits—including player-of-the-match awards, personal accolades, match fees, and bonuses—are disqualified, effective from the date the original sample was collected.
Crucially, the tribunal noted that this disqualification is limited to the player’s individual merits and does not extend to the results of his teams, meaning the Springboks’ and Lions’ collective victories remain on the record.
Timeline of the anti-doping proceedings
To understand the trajectory of the case, it is necessary to look at the sequence of events from the initial test to the final ruling. The following table outlines the key milestones in the proceedings:
| Date | Event Milestone |
|---|---|
| May 22, 2025 | Out-of-competition drug test conducted |
| August 2025 | Adverse analytical finding identified |
| September 9, 2025 | Formal charges issued for Anastrozole and DHEA |
| May 13, 2026 | Commencement of 18-month suspension |
| November 13, 2026 | Suspension ends (Day of World Cup final) |
Impact on the Lions and the Springboks
The news has sent ripples through the South African rugby community, particularly for the Lions Rugby Company. The franchise, where Ntlabakanye has been an ever-present figure in the United Rugby Championship, has expressed its intention to support the player through the legal process.
“The Lions Rugby Company confirms that it has received communication from the South African Institute for Drug-Free Sport, regarding the decision to sanction Lions prop Asenathi Ntlabakanye for a period of 18 months following an anti-doping rule violation,” the franchise said in an official statement. The club added that they, alongside MyPlayers and the Rugby Players’ Organisation, will deliberate on next steps while continuing to support Ntlabakanye as he navigates the process.
For the Springboks, the loss of the tighthead comes at a sensitive time for the national side. Ntlabakanye was a recent participant in the squad that secured a 73-0 victory over Wales during the November series. His absence will leave a gap in the scrum depth as the team prepares for the long road toward the 2027 World Cup.
The case also arrives amidst broader discussions regarding testing protocols in South African rugby. Recent reports have highlighted a perceived decrease in testing frequency following the Springboks’ back-to-back World Cup successes, adding a layer of scrutiny to how anti-doping measures are managed within the high-performance environment.
The legal road ahead and potential appeals
The decision by the independent panel is not necessarily the final word in this matter. Under the current anti-doping framework, several bodies have the right to challenge the ruling. Ntlabakanye, SAIDS, World Rugby, and the World Anti-Doping Agency (WADA) all have a 21-day window to submit an appeal to the Court of Arbitration for Sport (CAS).
SAIDS has indicated that it is currently reviewing the merits of the decision to determine whether an appeal will be lodged. A successful appeal could potentially alter the length of the suspension or the commencement date, which would fundamentally change the player’s eligibility for the 2027 World Cup.
For now, the player remains in a state of professional limbo, awaiting the outcome of the potential legal challenges that will decide whether he can return to the pitch before the global rugby community converges for the World Cup final.
Disclaimer: This article is for informational purposes only and does not constitute legal or medical advice.
We invite our readers to share their thoughts on this developing story. How should rugby governing bodies balance medical necessity with strict anti-doping enforcement? Leave a comment below or share this article on social media.
